US Guidelines Fall Short on Short-Course TB Preventive Therapy.
Sonya KrishnanRichard E ChaissonPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Provision of tuberculosis preventive therapy (TPT) to vulnerable populations is critical for global control. Shorter-course TPT regimens are highly effective and improve completion rates. Despite incorporation of one month of rifapentine and isoniazid into global guidelines, current United States TPT guidelines do not include this as a recommended regimen, but should.